NEW YORK (GenomeWeb News) – Saladax Biomedical today said that Lab21 will offer the firm's Personalized Chemotherapy Management assays as a service offering in the UK, Ireland, and Middle East, under a distribution agreement between the firms.

Bethlehem, Pa.-based Saladax said that Lab21 is the first clinical reference lab to offer testing services based on the firm's 5-fluorouracil PCM reagent kits. Cambridge, UK-based Lab21 will market the dose-management service under the trade name DoseCheck.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.